Sen­ate pro­pos­es $16B to fund the next wave of Covid-19 vac­cines, ther­a­peu­tics in 2023

Don’t call it Op­er­a­tion Warp Speed 2.0, but Sen­ate De­moc­rats on Thurs­day pro­posed $22 bil­lion in 2023 emer­gency sup­ple­men­tal fund­ing for the next phase of the pan­dem­ic, in­clud­ing $16 bil­lion to sup­port the R&D, man­u­fac­tur­ing, pur­chase, and dis­tri­b­u­tion of vac­cines, ther­a­peu­tics, di­ag­nos­tics and oth­er med­ical coun­ter­mea­sures.

The in­flux of new funds, if passed and agreed to with their House coun­ter­parts, would ar­rive as, ac­cord­ing to the US gov­ern­ment spend­ing web­site, Wash­ing­ton has al­ready spent $3.83 tril­lion in re­sponse to Covid-19.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER